HELLS was expressed in > 1% of tumor cells in 8/30 (27%) GS 4 + 3 = 7 cases as compared to 20/142 (14%) of GS 3 + 4 = 7 tumors (p = 0.09). This evidence concerns the gene HELLS and neoplasm.